Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/1167
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShrestha, Gentle Sunder-
dc.contributor.authorRimal, Ankit-
dc.date.accessioned2023-05-02T05:22:33Z-
dc.date.available2023-05-02T05:22:33Z-
dc.date.issued2021-
dc.identifier.citationShresthaG. S., & RimalA. (2021). Steroid Stewardship in COVID-19. Journal of Nepal Health Research Council, 19(03), 631-634. https://doi.org/10.33314/jnhrc.v19i3.3660en_US
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217-
dc.identifier.urihttp://103.69.126.140:8080/handle/20.500.14356/1167-
dc.descriptionShort Communicationen_US
dc.description.abstractAbstract Corticosteroids have transformed clinical practice in COVID-19 following the publication of the results of the RECOVERY trial. Despite available evidence, there is considerable disparity among physicians in the dose and duration of steroids they prescribe. Steroids have a fragile affiliation in clinical practice with the benefits frequently accompanied by distressing adverse effects. An institutional steroid stewardship program can help all physicians take advantage of what is the only proven therapy of benefit in this global crisis while avoiding its overuse and the numerous adverse effects associated with it. Keywords: COVID-19; corticosteroids; RECOVERY trial; steroid stewardshipen_US
dc.language.isoenen_US
dc.publisherNepal Health Research Councilen_US
dc.relation.ispartofseriesJuly-Sep, 2021;3660-
dc.subjectCOVID-19en_US
dc.subjectcorticosteroidsen_US
dc.subjectRECOVERY trialen_US
dc.subjectsteroid stewardshipen_US
dc.titleSteroid Stewardship in COVID-19en_US
dc.typeJournal Articleen_US
local.journal.categoryShort Communication-
Appears in Collections:Vol. 19 No. 03 (2021): Vol 19 No 3 Issue 52 Jul-Sep 2021

Files in This Item:
File Description SizeFormat 
3660-Manuscript-25088-1-10-20211215.pdfFulltext Download198.06 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.